Patrick Robberecht
#149,203
Most Influential Person Now
Patrick Robberecht's AcademicInfluence.com Rankings
Patrick Robberechtmedical Degrees
Medical
#2850
World Rank
#3292
Historical Rank
Pharmacology
#322
World Rank
#373
Historical Rank
Download Badge
Medical
Why Is Patrick Robberecht Influential?
(Suggest an Edit or Addition)Patrick Robberecht's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. (1998) (804)
- Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. (1994) (320)
- Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. (2004) (287)
- Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. (2000) (250)
- Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. (1992) (227)
- Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. (1995) (223)
- Development of High Affinity Selective VIP1 Receptor Agonists (1997) (206)
- Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate. (1976) (193)
- In Vitro Properties of a High Affinity Selective Antagonist of the VIP1 Receptor (1997) (190)
- The C-terminal Nonapeptide of Mature Chemerin Activates the Chemerin Receptor with Low Nanomolar Potency* (2004) (170)
- Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. (1994) (161)
- Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. (1985) (157)
- The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP2 Receptor Subclass (1997) (152)
- Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. (1995) (143)
- Identification and characterization of an endogenous chemotactic ligand specific for FPRL2 (2005) (124)
- Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. (1996) (121)
- Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4‐2J (1990) (121)
- Specific binding of vasoactive intestinal peptide to brain membranes from the guinea pig. (1978) (117)
- The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK (1990) (117)
- Relative quantitative analysis of glucagon receptor mRNA in rat tissues (1994) (113)
- Characterization of VIP‐sensitive adenylate cyclase in guinea pig brain (1977) (111)
- Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin. (1978) (110)
- Exocrine pancreas: evidence for topographic partition of secretory function (1975) (106)
- In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. (1976) (104)
- Primary structure of helodermin, a VIP‐secretin‐like peptide isolated from Gila monster venom (1984) (104)
- Rat pancreatic hydrolases from birth to weaning and dietary adaptation after weaning. (1971) (102)
- Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice (1998) (98)
- Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord (1991) (97)
- Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. (1995) (96)
- The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy (1999) (88)
- Desensitization of the Human Motilin Receptor by Motilides (2005) (88)
- Secretion of hydrolases by perfused fragments of rat pancreas: effect of calcium. (1971) (87)
- Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain (1997) (87)
- Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. (1995) (86)
- The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors (1996) (85)
- In vitro interactions of gastrointestinal hormones on cyclic adenosine 3':5'-monophosphate levels and amylase output in the rat pancreas. (1975) (84)
- VIP activation of rat anterior pituitary adenylate cyclase (1979) (84)
- Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction* (2001) (83)
- Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC2 receptor (2000) (82)
- Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. (1982) (82)
- Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes. (1981) (80)
- Short-term adaptation of pancreatic hydrolases to nutritional and physiological stimuli in adult rats. (1971) (79)
- Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. (1995) (78)
- The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. (1997) (74)
- Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology (1984) (73)
- Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. (2000) (73)
- The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors. (1983) (70)
- Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. (1985) (70)
- The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1–27) and PACAP (1–38)) interact with distinct receptors on rat pancreatic AR 4‐2J cell membranes (1991) (69)
- Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP‐ and secretin‐like properties (helodermin) from Gila monster venom (1984) (68)
- The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system. (1983) (67)
- Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. (1986) (67)
- Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type. (1987) (67)
- Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes. (1991) (65)
- Interaction of the Growth Hormone-Releasing Peptides Ghrelin and Growth Hormone-Releasing Peptide-6 with the Motilin Receptor in the Rabbit Gastric Antrum (2003) (63)
- PACAP and VIP receptors in rat liver membranes. (1991) (62)
- Prolactin cell subpopulations separated on discontinuous Percoll gradient: an immunocytochemical, biochemical, and physiological characterization. (1988) (62)
- Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig (1982) (62)
- Subcellular distribution and response to gastroinetstinal hormones of adenylate cyclase in the rat pancreas. Partial purification of a stable plasma membrane preparation. (1976) (61)
- Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties (1984) (59)
- Properties of the VIP-PACAP type II receptor stably expressed in CHO cells (1994) (59)
- Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. (2005) (59)
- In vivo effects of pancreozymin, secretin, vasoactive intestinal polypeptide and pilocarpine on the levels of cyclic AMP and cyclic GMP in the rat pancreas (1974) (58)
- Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes. (1992) (58)
- Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21. (1992) (56)
- Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine (2005) (55)
- Chemical, immunological and biological properties of peptides like vasoactive-intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum). (1987) (54)
- Role of VIP1/PACAP receptors in postoperative ileus in rats (1998) (53)
- The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes. (1998) (53)
- Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide. (1992) (53)
- VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor (1996) (52)
- Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. (1999) (51)
- Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments. (1981) (51)
- Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland (1998) (50)
- Hormonal and dietary adaptation of rat pancreatic hydrolases before and after weaning. (1974) (50)
- Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells. (1995) (49)
- Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas. (1993) (49)
- Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues. (1982) (49)
- Effects of alcohols on the actions of VIP and secretin on acinar cells from guinea pig pancreas. (1979) (48)
- Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes. (1986) (48)
- Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function. (1997) (47)
- Immunoreactive helodermin-like peptides in rat: a new class of mammalian neuropeptides related to secretin and VIP. (1985) (45)
- A cDNA construct allowing the expression of rat hepatic glucagon receptors. (1993) (45)
- Effects of somatostatin on pancreatic exocrine function. Interaction with secretin. (1975) (44)
- Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors (1994) (44)
- Comparison of β-adrenergic receptors and the adenylate cyclase system with muscarinic receptors and guanylate cyclase activities in the heart of spontaneously hypertensive rats (1981) (44)
- Activation of p38 and p42/44 MAP kinase in neuropathic pain: Involvement of VPAC2 and NK2 receptors and mediation by spinal glia (2005) (44)
- Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. (1994) (43)
- Pancreatic secretion of total protein and of three hydrolases collected in healthy subjects via duodenoscopic cannulation. Effects of secretin, pancreozymin, and caerulein. (1975) (42)
- Ala-scan of ghrelin (1–14): interaction with the recombinant human ghrelin receptor (2004) (42)
- Effects of HIS1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues (1984) (41)
- Early decrease in secretin-, glucagon-, and isoproterenol-stimulated cardiac adenylate cyclase activity in rats treated with isoproterenol. (1982) (41)
- Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas (1996) (40)
- Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors. (2001) (39)
- Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors. (2007) (39)
- Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes. (1984) (39)
- Effects of verapamil on the binding properties of rat heart muscarinic receptors: evidence for an allosteric site. (1984) (39)
- Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells. (1994) (39)
- Low responsiveness of cardiac adenylate cyclase activity to peptide hormones in spontaneously hypertensive rats (1979) (39)
- Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes (1989) (38)
- The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes. (1991) (38)
- Vasoactive Intestinal Peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes (1982) (37)
- Influence of selective VIP receptor agonists in the rat gastric fundus. (1998) (37)
- Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor. (1996) (37)
- Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue. (2002) (37)
- Postnatal development of the cholecystokinin-gastrin family of peptides in the brain and gut of rat. (1980) (36)
- CCK and gastrin inhibit adenylate cyclase activity through a pertussis toxin‐sensitive mechanism in the tumoral rat pancreatic acinar cell line AR 4‐2J (1988) (36)
- Isolation and primary structure of rat secretin. (1989) (36)
- Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor (1995) (36)
- Factors regulating biosynthesis, intracellular transport and secretion of amylase and lipase in the rat exocrine pancreas. (1971) (36)
- Secretin Receptors in Human Pancreatic Membranes (1988) (35)
- Specificity of receptors to vasoactive intestinal peptide in guinea pig brain. (1979) (35)
- Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states. (1996) (35)
- Differential alternative splicing of PACAP receptor in pituitary cell subpopulations (1995) (35)
- Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors. (1998) (34)
- Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality☆ (1999) (34)
- Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands. (1999) (34)
- Analogues of VIP, Helodermin, and PACAP Discriminate between Rat and Human VIP1 and VIP2 Receptors a (1998) (34)
- Heterogeneity of VIP receptors. (1990) (34)
- Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11. (1997) (34)
- Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors. (1996) (33)
- Effect of pituitary adenylate cyclase-activating polypeptide 38 on growth hormone and prolactin expression. (1994) (33)
- The in vitro chronotropic and inotropic effects of vasoactive intestinal peptide (VIP) on the atria and ventricular papillary muscle from Cynomolgus monkey heart (1984) (32)
- Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin. (1996) (32)
- Decreased stimulation of adenylate cyclase by growth hormone-releasing factor in the anterior pituitary of old rats. (1986) (31)
- "In vitro" effects of secretin and vasoactive intestinal polypeptide on hydrolase secretion and cylic AMP levels in the pancreas of five animal species. A comparison with caerulein. (1977) (30)
- Contribution of the Carboxyl Terminus of the VPAC1 Receptor to Agonist-induced Receptor Phosphorylation, Internalization, and Recycling* (2005) (30)
- Is helodermin produced by medullary thyroid carcinoma cells and normal C-cells? Immunocytochemical evidence (1988) (30)
- C-Terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors (1996) (30)
- The interaction of caerulein with the rat pancreas. 2. Specific binding of [3H]caerulein on dispersed acinar cells. (1978) (29)
- Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation. (2005) (29)
- RDC1 may not be VIP receptor. (1992) (29)
- Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes. (1998) (29)
- Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy. (2009) (28)
- Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation. (1999) (28)
- Comparison of VIP-secretin receptors in rat and human lung (1981) (28)
- Characterization of the VIP receptor from SUP T1 lymphoblasts. (1996) (28)
- Amino acid sequence of VIP, PHI and secretin from the rabbit small intestine (1990) (28)
- The interaction of caerulein with the rat pancreas. 3. Structural requirements for in vitro binding of caerulein-like peptides and its relationship to increased calcium outflux, adenylate cyclase activation, and secretion. (1978) (28)
- Discharge of newly synthesized proteins in pure juice collected from the human pancreas. Indication of more than one pool of intracellular digestive enzymes. (1977) (27)
- Pharmacological characterization of VIP receptors in human lung membranes (1988) (27)
- Helodermin has a VIP-like effect upon canine blood flow (1986) (27)
- VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling. (2011) (26)
- The interaction of caerulein with the rat pancreas. 1. Specific binding of [3H]caerulein on plasma membranes and evidence for negative cooperativity. (1978) (26)
- Presence of helodermin‐like peptides of the VIP‐secretin family in mammalian salivary glands and saliva (1985) (26)
- Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain (1998) (26)
- Vasoactive intestinal peptide (VIP) stimulates [Ca2+]iand cyclic AMPin CHO cells expressing Gα16 (2001) (26)
- Association of binding sites for guanine nucleotides with adenylate cyclase activation in rat pancreatic plasma membranes. Interaction of gastrointestinal hormones. (1978) (25)
- Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42). (1989) (25)
- Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptides and beta-adrenergic agonists in murine T cell lymphomas of immature, helper, and cytotoxic types. (1989) (25)
- Inhibitory pathways in the circular muscle of rat jejunum (2004) (25)
- Specific binding of the calcium-dependent regulation protein to brain membranes from the guinea pig. (1978) (24)
- Hydrolysis of the cyclic 3':5'-monophosphates of adenosine and guanosine by rat pancreas. (1974) (23)
- Expression of pituitary adenylate cyclase activating polypeptide and receptors in human brain tumors (1995) (23)
- Comparative effects of α-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats (1981) (23)
- Impairment of &bgr;-Adrenergic Signaling in Healthy Peripheral Blood Mononuclear Cells Exposed to Serum from Patients with Septic Shock: Involvement of the Inhibitory Pathway of Adenylyl Cyclase Stimulation (2003) (23)
- Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23. (1994) (22)
- Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas (1986) (22)
- Evidence for VIP1/PACAP receptors in the afferent pathway mediating surgery‐induced fundic relaxation in the rat (2000) (22)
- Effector mechanisms of peptides of the VIP family (1986) (22)
- Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides. (1980) (22)
- VIP and PACAP 38 Modulate Ibotenate‐Induced Neuronal Heterotopias in the Newborn Hamster Neocortex (2000) (21)
- Overexpression of pterin-4a-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 in human colon cancer. (1999) (21)
- Evidence against VIP as the inhibitory transmitter in non‐adrenergic, non‐cholinergic nerves supplying the longitudinal muscle of the mouse colon (1986) (20)
- Inhibitory effects of quinidine on rat heart muscarinic receptors. (1984) (20)
- Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor. (2006) (20)
- A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector. (2002) (20)
- Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor (2005) (20)
- Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor. (1999) (20)
- Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor. (2005) (20)
- Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC2: role of basic residues in the second transmembrane helix (2001) (19)
- VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line (1989) (19)
- Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2) (2006) (19)
- Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine. (1988) (19)
- Receptors involved in helodermin action on rat pancreatic acini. (1986) (18)
- Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency (2004) (18)
- Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3. (1989) (18)
- Inhibition of Forskolin‐stimulated cardiac adenylate cyclase activity by short‐chain alcohols (1983) (18)
- Expression of transforming growth factor beta receptors in normal human colon and sporadic adenocarcinomas. (1998) (17)
- Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells (2004) (17)
- Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues (1997) (17)
- [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. (1987) (17)
- Rat PHI, PHI-GLY and PHV(1–42) stimulate adenylate cyclase in six rat tissue and cell membranes (1990) (17)
- Secretin receptors in the neuroglioma hybrid cell line NG108-15. Characterization and regulation of their expression. (1990) (17)
- Vasoactive intestinal polypeptide receptor VPAC1 subtype is predominant in rat prostate membranes (1999) (17)
- Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors. (1983) (17)
- Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide (1-27) and secretin from the small intestine of guinea pig. (1990) (17)
- Helodermin‐like Peptides (1988) (16)
- Species differences in the molecular characteristics of vasoactive-intestinal-peptide receptors in the pancreas from rat and guinea-pig. (1988) (16)
- Molecular cloning and in vitro properties of the recombinant rabbit secretin receptor (1998) (16)
- Heterogeneity of VIP-recogizing binding sites in rat tissues (1982) (16)
- Specific binding of [3H] caerulein on rat pancreatic plasma membranes: binding characteristics and correlation with adenylate cyclase activation (1976) (15)
- Evidence for a Direct and Functional Interaction between the Regulators of G Protein Signaling-2 and Phosphorylated C Terminus of Cholecystokinin-2 Receptor (2009) (15)
- Peptide histidine isoleucinamide (PHI)-(1-27)-Gly as a new major form of PHI in the rat small intestine. (1989) (15)
- Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide and secretin from the ovine small intestine (1991) (14)
- Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2, 3, 4, 25, 27 and/or 29 (1988) (14)
- Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists (2003) (14)
- Effects of temperature and ethanol on agonist and antagonist binding to rat heart muscarinic receptors in the absence and presence of GTP. (1985) (14)
- A Critical View of the Methods for Characterization of the VIP/PACAP Receptor Subclasses a (1998) (13)
- Isolation and Primary Structure of the CCI Papain-Like Cysteine Proteinases from the Latex of Carica candamarcensis Hook (1999) (12)
- Molecular basis of enzyme secretion by the exocrine pancreas. (1974) (12)
- Impairment of Hormone-Stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat (1981) (12)
- Increased number of high-affinity muscarinic receptors in rat heart after phenylhydrazine treatment. (1983) (12)
- Effect of VIP on the exocrine pancreas (1982) (12)
- Structural requirements for the occupancy of rat brain PACAP receptors and adenylate cyclase activation (1994) (12)
- Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardium (1985) (12)
- Secretin and VIP-stimulated adenylate cyclase from rat heart (1980) (12)
- Bradykinin action in the rat duodenum: receptor binding and influence on the cyclic AMP system. (1987) (12)
- VIP receptors in human SUP-T1 lymphoblasts. (1990) (12)
- Deactivation of persistently activated pancreatic adenylate cyclase. Evidence of uncoupling of hormone receptors and enzyme effector in the persistently activated state, and of the presence of two guanyl nucleotide regulatory sites (1978) (11)
- Interaction of Gila monster venom with secretin receptors in rat pancreatic membranes (1984) (11)
- The VIP/PHI/secretin/helodermin/helospectin/GRF family: structure-function relationship of the natural peptides, their precursors and synthetic analogues as tested in vitro on receptors and adenylate cyclase in a panel of tissue membranes (1989) (11)
- Alterations of rat cardiac adenylate cyclase activity with age. (1986) (11)
- Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy. (1982) (11)
- Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats (1984) (10)
- Vasoactive intestinal peptide: levels and functional receptors in rat brain before and after weaning. (1979) (10)
- Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species (1983) (10)
- Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor. (2003) (10)
- Ribonucleotide reductase and thymidine phosphorylation: two potential targets of azodicarbonamide. (2002) (10)
- Comparative efficacy of seven synthetic glucagon analogs, modified in position 1, 2 and/or 12, on liver and heart adenylate cyclase from rat (1986) (10)
- Natriuretic Peptide Receptors of Type A in Human Neuroblastomas (1999) (9)
- Pancreatic secretory factor (PSF), a protein from Gila monster venom stimulating enzyme secretion from rat pancreatic acini (1984) (9)
- Characterization of a novel VPAC1 selective agonist and identification of the receptor domains implicated in the carboxyl‐terminal peptide recognition (2000) (9)
- Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptors (1986) (9)
- Species variations and physiopathology of VIP-PHI-secretin receptors in heart and lung (1983) (9)
- Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase. (1983) (9)
- Eriochrome Black T inhibits endothelial cell growth through S-phase blockade. (2000) (9)
- Amino acid levels in rat pancreas after pilocarpine or pancreozymin. (1973) (9)
- Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland. (1996) (8)
- Selective alteration of secretin-stimulated cardiac adenylate cyclase activity in streptozotocin-diabetic rats. (1983) (8)
- Homologous and heterologous regulation of the helodermin/vasoactive-intestinal-peptide response in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3. (1989) (8)
- Coexistence of non-adrenergic non-cholinergic inhibitory and excitatory neurotransmitters in a large neuronal subpopulation in the vaginal segment of the chicken oviduct (2004) (8)
- Cell surface targeting of VPAC1 receptors: evidence for implication of a quality control system and the proteasome. (2008) (8)
- Decreased secretin and glucagon responsiveness of adenylate cyclase in cardiac membranes from hypothyroid rats (1981) (8)
- The pancreatic secretion of zinc in man and rat. (1980) (8)
- Secretin and VIP-stimulated adenylate cyclase from rat heart (1980) (8)
- Gastrointestinal hormone-receptor interactions in the pancreas (1980) (8)
- Propylbenzilylcholine mustard is selective for rat heart muscarinic receptors having a low affinity for agonists (1986) (8)
- Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity. (2002) (8)
- Plasma cyclic AMP levels during a secretin-caerulein pancreatic function test in liver and pancreatic disease. (1978) (7)
- Evidence for multiple rat VPAC1 receptor states with different affinities for agonists. (1999) (7)
- Variable distribution, in four rat brain areas, of the three natural forms of peptide histidine isoleucinamide: PHI(1-27)NH2, PHI-Gly, and PHV (1-42). (1991) (7)
- Evidence that the chromogranin B fragment 368–417 extracted from a pheochromocytoma is phosphorylated (2001) (7)
- Hydrolases content in peri-insular and tele-insular exocrine pancreas (1976) (7)
- Proceedings: Biochemical studies on pure pancreatic juice obtained by duodenoscopic cannulation of the pancreatic duct in conscious patients. (1974) (7)
- Cells retrovirally transfected with fibroblast growth factor-2 isoforms exhibit altered adenylate cyclase activity and G-protein functionality. (1996) (7)
- The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors. (1983) (7)
- Evidence that the lizard helospectin peptides are O-glycosylated. (2000) (7)
- Effects of a chemical sympathectomy on cardiac muscarinic receptors in normotensive (WKY) and spontaneously hypertensive (SHR) rats. (1983) (6)
- Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16. (2001) (6)
- Multiple effects of short-chain alcohols on binding to rat heart muscarinic receptors. (1984) (6)
- Divergent regulation of beta 2-adrenoceptors and adenylate cyclase in the Cyc- mouse T lymphoma cell line TL2-9. (1990) (6)
- Molecular characterization of helodermin-preferring VIP receptors in SUP T1 lymphoma cells: evidence for receptor glycosylation. (1991) (6)
- Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria (1984) (6)
- Distribution of PACAP-38 and PACAP-27 in rat brain (1992) (6)
- In vivo effects of five secretin analogs on fluid and potassium secretion from the rat pancreas. (1980) (6)
- Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation (2002) (6)
- VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cells. (2002) (6)
- Evidence for topographic partition of secretory function in the exocrine pancreas (1975) (6)
- Identification of secretin, vasoactive intestinal peptide and glucagon binding sites: from chimaeric receptors to point mutations. (2001) (6)
- Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes. (1988) (5)
- Interaction of Gila Monster venom with secretin receptors in rat pancreatic membranes (1983) (5)
- The phorbol ester TPA stimulates the expression of functional beta-adrenoceptors in human T lymphoblasts Molt 3. (1989) (5)
- Chromogranin A(210–301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors (1994) (5)
- [Secretion of hydrolases by perfused fragments of rat pancreas]. (1970) (5)
- Ac His1 [d-Phe2, K15, R16, L27] VIP (3–7)/GRF (8–27) – a VPAC1 receptor antagonist – is an inverse agonist on two constitutively active truncated VPAC1 receptors (2004) (5)
- Development of Selective Ligands for Pac1, Vpac1 and Vpac2 Receptors (2003) (5)
- Thermodependence of guanine nucleotide-activated rat cardiac adenylate cyclase activity. Effect of cholera toxin pretreatment. (1982) (5)
- Localization of transforming growth factor-β1 precursor and latent TGF-β1 binding protein in colorectal adenomas (1996) (5)
- Decreased adenylate cyclase activation by helodermin and PGE1 in the lectin-resistant variant Wa4 of the mouse melanoma cell line B16 (1989) (5)
- Structural requirements for the occupancy of rat brain PACAP receptors and adenylate cyclase activation (1992) (5)
- Specific labelling of high-affinity vasoactive intestinal peptide receptors in rat liver membranes by a growth hormone-releasing factor analog. (1986) (4)
- A comparison between muscarinic receptor occupancy, adenylate cyclase inhibition, and inotropic response in human heart (1984) (4)
- Recovery of VIP/helodermin- and prostaglandin E1-stimulated adenylate cyclase activities in desensitized SUP-T1 human lymphoblasts (1989) (4)
- Properties of a recombinant human secretin receptor: a comparison with the rat and rabbit receptors. (1999) (4)
- [Value of a model of isolated exocrine pancreatic, gastric and small intestine cells for research in gastroenterology]. (1979) (4)
- Characterization of functional VIP/PACAP receptors in the human erythroleukemic HEL cell line (2001) (4)
- Function, biosynthesis, secretion and intestinal degradation of a pancreatic hydrolase: the lipase of the rat exocrine pancreas. (1971) (4)
- Current status on chromogranin A and pancreastatin. (1993) (4)
- Promotion by Mg2+ of guanosine 5′‐(β,γ‐imido)triphosphate activation of adenylate cyclase in rat lung and heart membranes (1982) (4)
- Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung (1981) (4)
- Binding, dissociation, and mode of action of caerulein and Gpp(NH)p on the rat exocrine pancreas (1977) (4)
- Wheat germ agglutinin inhibits basal- and stimulated-adenylate cyclase activity as well as the binding of [3H] caerulein to rat pancreatic plasma membranes. (1977) (4)
- Regulation of the dissociation of [3H] caerulein from its pancreatic receptors: evidence for negative cooperativity (1976) (3)
- Comparative structural requirements of GRF analogs for occupancy of GRF and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas (1985) (3)
- Presence of calcitonin gene-related peptide receptors coupled to adenylate cyclase in human gliomas (1994) (3)
- Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor. (2003) (3)
- The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats (1983) (3)
- Alteration of secretin-stimulated cardiac adenylate cyclase activity in rats with portacaval shunt (1986) (3)
- Mixed phenotype murine leukemias. (1993) (3)
- Helodermin-like immunoreactivity is artefactually increased in bovine brain by the presence of calmodulin (1992) (3)
- Comparative effects of alpha-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats. (1981) (3)
- Interaction of synthetic N-and C-terminal fragments of helodermin with rat liver VIP receptors (1985) (3)
- Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes. (1981) (3)
- Inhibition by heparin and dextran sulfate of stimulated rat pancreatic adenylate cyclase. (1981) (2)
- Thermodependence of basal and stimulated cardiac adenylate cyclase activity in normotensive and spontaneously hypertensive rats. (1983) (2)
- Modulation by n-alkanols of rat cardiac adenylate cyclase activity. (1986) (2)
- The pituitary VIP-sensitive adenylate cyclase (1979) (2)
- VIP-helodermin receptors in the murine virus-induced T lymphoma cell line BL/VL3 recover less rapidly than beta-adrenoceptors after down regulation. (1989) (2)
- Overexpression of Pterin-4 a-carbinolamine Dehydratase / Dimerization Cofactor of Hepatocyte Nuclear Factor 1 in Human Colon Cancer (1999) (2)
- [Interaction of gastrointestinal hormones with pancreatic cells in the rat]. (1974) (2)
- The influence of detergents and trypsin on the stimulation of amylase secretion by either pancreozymin or sodium fluoride in the perfused rat pancreas. (1975) (2)
- A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector. (2002) (2)
- Human A-type ANP receptor upregulation by PACAP and carbachol in neuroblastoma cells (1999) (2)
- Modulation byn-alkanols of rat cardiac adenylate cyclase activity (2005) (2)
- Multiple differences between wild-type B16 melanoma cells and a wheat germ agglutinin resistant clone. (1991) (2)
- Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings]. (1979) (2)
- The C-terminal domain of motilin is required for complete homologous desensitization and endocytosis (2003) (2)
- Existence of multiple forms of biologically active cholecystokinin-pancreozymin-like peptides in rat brain (1978) (2)
- Cholera toxin pretreatment of the human lymphoblastic cell line sup T1 affects the selectivity of helodermin/VIP receptors (1989) (2)
- PACAP receptors in human neuroblastoma NB-OK-1 cell membranes (1992) (2)
- [Dietetic induction of pancreatic hydrolases in weaned rats]. (1971) (1)
- VIP-secretin receptors in rat heart: A comparison with similar receptors in other tissues and possible pathophysiologic implications (1981) (1)
- Binding sites and response of rat pancreatic acini to Helodermin (Hd) (1985) (1)
- Ontogenic development of PACAP and PACAP receptors in rat brain (1992) (1)
- PACAP increases [Ca2+]i in single human neuroblastoma NB-OK-1 cells (1992) (1)
- Differences in the ability of motilides to induce motilin receptor internalization underly their desensitizing capacity (2003) (1)
- Immunoreactive helodermin: A new candidate neuropeptide in mammalian (1985) (1)
- Comparison of beta-adrenergic receptors and the adenylate cyclase system with muscarinic receptors and guanylate cyclase activities in the heart of spontaneously hypertensive rats. (1981) (1)
- Proceedings: Variations in cyclic AMP levels in the epididymal adipose tissue of normal and congenitally obese mice. (1975) (1)
- Overexpression of pterin-4a-carbinolamine dehydratase in colon cancers (1998) (1)
- Comparative in vitro effects of guinea pig VIP and common VIP on liver and lung membranes from guinea pig and rat and on human lymphoblastic SUP-T1 membranes (1991) (1)
- Helodermin and Helospectin‐like Peptides Present in the Venom of the Lizards Heloderma horridum and Heloderma suspectum (1988) (1)
- Cyclic AMP levels in adipose tissue of normal and obese-hyperglycemic (ob/ob) mice (1975) (1)
- Desensitization and recovery of prostaglandin-stimulated adenylate cyclase activity in a murine virus-induced T lymphoma cell line BL/VL3. (1989) (1)
- Effects oftemperature andethanol on agonist andantagonist binding toratheart muscarinic receptors intheabsence and presenceofGTP (1985) (1)
- Heterogeneity of Vip-Secretin Receptors in three Rat Tissues (1982) (1)
- [Recombinant receptors for testing agonists and antagonists of VIP and PACAP receptors]. (1996) (1)
- Interleukin-10 (IL-10) decreases severity of acute necrotizing pancreatitis in mice (1995) (1)
- Secretin-VIP receptor interactions (1978) (1)
- From lizard helodermin to mammalian helodermin- and pacap-preferring VIP receptors (1993) (1)
- Effect ofpHonbinding ofagonists andantagonists toratheart muscarinic receptors (1983) (1)
- Sequences (103–110) and (116–120) of the Rat Secretin Receptor are Implicated in Secretin and VIP Recognition (2000) (1)
- Effects of somatostatin on pancreatic exocrine function. Interaction with secretin. (1975) (1)
- Presence of functional high-affinity atrial natriuretic peptide receptors in membranes from the human neuroblastoma cell line NB-OK-1 (1990) (1)
- Characterization of rat cardiac secretin(Sn)-VIP stimulated adenylate cyclase: A coiparison with pancreas, liver, and brain (1980) (1)
- Stimulus-secretion coupling in pancreatic acinar cells exposed to pancreozymin: Membranous and intra-cellular phenomena (1980) (1)
- Identification of the Secretin, VIP and glucagon binding sites: from chimeric receptors to point mutations (2002) (1)
- Liver Disease and Plasma Cyclic AMP (1979) (1)
- Effect of positive charge in VIP 16γ‐glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function (2008) (1)
- Effect of the peptides of the VIP family on the cardiovascular system (1985) (1)
- PACAP receptors in rat pancreatic acinar AR 4-2J cell membranes (1992) (1)
- Agonistic and antagonistic properties of C-terminal fragments of the pituitary adenylate cyclase activating peptides (PACAPs) (1992) (1)
- Assays for Secretin Receptors: Comparison between Neuroblastoma Cells and Exocrine Pancreas (1991) (1)
- [Adenylate cyclase activity and intracellular levels of cyclic AMP in rat exocrine pancreas]. (1973) (1)
- [Dietetic adaptation of pancreatic lipase and amylase in the rat]. (1971) (0)
- Comparative efficacy of synthetic glucagon analogs on rat liver and heart adenylate cyclase (1985) (0)
- Specific impairment of secretin- and VIP-stimulated adenylate cyclase activity in the heart of Zucker fatty (fa/fa) rats (1980) (0)
- Effects of gastrointestinal hormones on the levels of cyclic AMP and cyclic GMP in the rat pancreas (1974) (0)
- THE INFLUENCE OF DETERGENTS A ND TRYPSIN ON THE STIMULATION OF AMYLASE SECRETION BY EITHER PANCREOZYMIN OR SODIUM FLUORIDE IN THE PERFUSED RAT PANCREAS (2019) (0)
- Binding of [3H]caerulein to rat pancreatic plasma membranes. (1976) (0)
- Effect of VIP, PHI and secretin on heart and lung membranes in man and rat (1983) (0)
- In vivo regulation of secretin-VIP receptors in rat heart ventricles (1983) (0)
- Biochemical basis of action of gastrointestinal hormones. Invited commentary. (1979) (0)
- Different Domains of the VIP Receptors Modulate Agonist Affinity and Intrinsic Activity (2000) (0)
- [The VIP peptidergic system. Role in pathology and therapeutics (author's transl)]. (1981) (0)
- In vivo and in vitro evidence for a direct effect of bombesin and litorin on the rat pancreas (1977) (0)
- Effects of bombesin and litorin on the rat exocrine pancreas: comparison with caerulein, carbamoylcholine and secretin. (1975) (0)
- Receptors for secretin, helodermin, VIP (vasoactive intestinal peptide), PHI and GRF (growth hormone releasing factot) in the rat pancreas (1985) (0)
- Vasoactive intestinal polypeptide receptors in rat and guinea pig brain (1979) (0)
- mustard isselective forratheart muscarinic receptors having alowaffinity foragonists (1986) (0)
- New perspectives in cardiac receptors. (1991) (0)
- Evidence for a direct interaction between the Thr 11 residue of vasoactive intestinal polypeptide and Tyr 184 located in the first extracellular loop of the (2003) (0)
- Invited commentary (1979) (0)
- [The sensitivity of the perfused pancreas to osmotic pressure]. (1973) (0)
- [The cellular biology of the exocrine pancreas]. (1972) (0)
- [Effects of pilocarpine injection on hydrolases and free amino acid contents of rat exocrine pancreas]. (1971) (0)
- Contents to volume 262 (2001) (0)
- Structure of the secretin receptor. A mutagenesis analysis (1997) (0)
- Assays for Pituitary Adenylate Cyclase-Activating Peptide Receptors Coupled to Adenylate Cyclase: Comparison between Rat Brain and Human Neuroblastoma Cells (1993) (0)
- Localization of transforming growth factor-beta 1 precursor and latent TGF-beta 1 binding protein in colorectal adenomas. (1996) (0)
- Direct interaction between the threonine 11 of Vasoactive Intestinal Polypeptide (VIP) and tyrosine 184 of the VPAC2 receptor (2002) (0)
- Interaction of the growth hormone releasing peptides, ghrelin and GHRP-6, with the motilin receptor in the rabbit gastric antrum. (2003) (0)
- Action of secretin and vasoactive intestinal peptide (VIP) on the adenylate cyclase system of pancreatic acinar cells (1978) (0)
- Ontogenic development of PHI-imminuoreactive forms in the brain, stomach and small intestine of rat (1989) (0)
- Subject Index, Vol. 46, Supplement 2, 1990 (1990) (0)
- Detection of circulating micrometastases from gastrointestinal tumors using RT-PCR: Maybe not so promising (1998) (0)
- Lessons from the Type II Family of G-Protein-Coupled Receptors A small sequence in the third intracellular loop of the VPAC , receptor is responsible for i ts efficient coupling to the calcium effector (2009) (0)
- Characterization of Vasoactive Intestinal Peptide Receptors in the Pancreatic AR 4‐2J Cell Line (1988) (0)
- Study of agonist-dependent VPAC1 receptor phosphorylation (2002) (0)
- Specific Binding and Ability of Vasoactive Intestinal Octacosa-Peptide (VIP) to Activate Adenylate Cyclase in Isolated Pancreatic Acinar Cells from the Guinea Pig (1976) (0)
- β‐Adrenergic Receptors and Adenylate Cyclase Activity in Erythrocyte Membranes from Spontaneously Hypertensive Rats (1986) (0)
- [Is vasoactive intestinal peptide (VIP) an essential neuropeptide for the heart?]. (1984) (0)
- [Gut receptors for hormonal peptides (author's transl)]. (1981) (0)
- Effects of HIS^ Modifications on the Ability of Vasoactive Intestinal Peptide to Stimulate Adenylate Cyclase From Rat and Human Tissues (2019) (0)
- Specific radioimmunoassay for the detection of the biological form of ghrelin (2003) (0)
- ["Turnover" of hydrolases in the rat pancreas at the end of protein malnutrition]. (1967) (0)
- Role of VIP1/PACAP receptors in experimental ileus in rats (1998) (0)
- Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptor (2006) (0)
- Gut Peptide Receptors and Signal Transmission in the Exocrine Pancreas and in the Pancreatic Acinar Cell Line AR 4-2J (1992) (0)
- [Carcinoid tumours and carcinoid syndrome. Clinical and biochemical aspects (author's transl)]. (1981) (0)
- Effect of deficiency of lysine on the content of hydrolases in the pancreas and small intestine of the rat. (1966) (0)
- Impaired Secretin-VIP Sensitivity of Adenylate Cyclase in the Heart of Congenitally Hypertensive (SHR) or Obese (fa/fa) Rats (1982) (0)
- [Cyclic nucleotide phosphodiesterases in rat pancreas]. (1973) (0)
- Control of intracellular levels of cyclic nucleotides in the exocrine pancreas (1974) (0)
- β-Adrenergic Receptors Subtypes in Myocardium (1988) (0)
- LE SYSTEME PEPTIDERGIQUE DU VIP (PEPTIDE VASOACTIF INTESTINAL): IMPLICATIONS EN PATHOLOGIE ET PERSPECTIVES THERAPEUTIQUES (1981) (0)
- [Hormone and neuroeffector receptors in gastroenterology. A concrete example: the VIP (vasoactive intestinal peptide) receptors]. (1982) (0)
- Demonstration ofbiological activity ofbrain gastrin-like peptidic material inthehuman:Itsrelationship withtheCOOH-terminal octapeptide ofcholecystokinin (1978) (0)
- [Membrane receptors of vasoactive intestinal peptide (VIP): hormone and neurotransmitter (proceedings)]. (1978) (0)
- ORIGIN AND POSSIBLE ROLE OF CYCLIC GMP AND CYCLIC AMP IN RAT AND GUINEA PIG PANCREATIC ACINAR CELLS (1981) (0)
- Contractile effects of ghrelin and of the growth-hormone releasing peptide, GHRP-6, in the rabbit antrum (2002) (0)
- Amino acid sequences, tissue distribution and in vitro biological properties of three forms of rat PHI (1989) (0)
- The VIP receptors of the guinea pig brain: Binding of VIP to- and adenylate cyclase activation of a synaptic membrane fraction (1978) (0)
- MOLECULAR CHARACTERIZATION OF HELODERMIN-PREFERRING EVIDENCE FOR RECEPTOR GLYCOSYLATION. VIP RECEPTORS IN SUP TI LYMPHOMA CELLS: (1991) (0)
- Comparative structural requirements of GRF analogs for occupancy and coupling to adenylate cyclase of GRF- and VIP receptors (1985) (0)
- Identification of receptors for PACAP in human brain tumors: A preliminary report of 20 cases (1992) (0)
- The Pathogenesis of Postoperative Ileus in the Rat: Roles of Nitric Oxide, Vasoactive Intestinal Polypeptide and к-Opioid Receptors (1999) (0)
- A new mechanism of G protein coupled receptor regulation through direct interaction between RGS2 and phosphorylated C-terminus of cholecystokinin receptor (2006) (0)
- Specific decrease of secretin-stimulated adenylate cyclase in heart membranes from hypertensive rats from the Lyon strain (LH) (1983) (0)
- Hormone-receptor interactions in the gastrointestinal tract ; the pancreatic acinar cell as a model target in gut endocrinology (1977) (0)
- Receptors Subtypes in Myocardium (1988) (0)
- [Synthesis and excretion of pancreatic hydrolases inhibited by protein malnutrition in the rat]. (1967) (0)
- Induction of pancreatic hydrolases by diet in weaned rats. (1971) (0)
- Human lung VIP-receptors in health and cancer (1983) (0)
- Functional Structure of the Secretin Receptor (2001) (0)
- Turnover of hydrolases in pancreas of the rat after protein malnutrition. (1967) (0)
- Subject Index Vol. 44, 1986 (1986) (0)
- Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in dog ischaemic myocardium (1985) (0)
- Chimeric VIP1/VIP2 receptors reveal the receptor domains involved in the recognition of selective ligands (1998) (0)
- Using vip analog for prevention and treatment of brain damage from human newborn (1999) (0)
- [Stimulation of cyclic AMP and cyclic GMP in rat pancreas stimulated by gastro-intestinal hormones in vivo and in vitro]. (1974) (0)
- Characterization and control of expression of secretin receptors in the neuroblastoma-glioma hybrid NG 108-15 (1989) (0)
- Promotion by Mg2+ of guanosine 5'-(beta, gamma-imido) triphosphate activation of adenylate cyclase in rat lung and heart membranes. (1982) (0)
- Adaptation of pancreatic lipase and amylase to diet in rats. (1971) (0)
- Purification of a novel pancreatic secretory factor. Arch. internat. Physiol. Bioch. 92, B66, 1984. (1984) (0)
- Binding Ca++ dependent heat stable phosphodiesterase modulator on brain synaptic membranes (1979) (0)
- Method of inhibiting cell cytokine production. (1997) (0)
- Growth factors in colorectal tumorigenesis. (1995) (0)
- Preventing and/or treating cerebral lesions in fetal, premature neonatal, full-term neonatal or young infant humans (1998) (0)
- Vasoactive Intestinal Peptide / Pituitary Adenylate Cyclase-activating Peptide Receptor Subtypes in Human Tumors and Their Tissues of Origin 1 (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Patrick Robberecht?
Patrick Robberecht is affiliated with the following schools:
